Definiendo el perfil del paciente candidato a 2 línea tras ITK

Cover

Table of Contents

Table of Contents

Previous Page

24 / 34

Next Page

Information

Previous Page

24 / 34

Next Page

Page Background

Nivolumab:

Treatment-related Adverse Events

>25% incidence in any arm

European Medicines Agency. 2016. Nivolumab EPAR Assessment

1 … 19 20 21 22 23 24 25 26 27 28 29 30 … 34 FlippingBook